Logo

Harrow Health, Inc.

HROW

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of the… read more

Healthcare

Drug Manufacturers—Specialty & Generic

16 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$48.50

Price

+0.66%

$0.32

Market Cap

$1.794b

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$227.661m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$10.228m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$0.30

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$49.299m

$345.033m

Assets

$295.734m

Liabilities

$231.251m

Debt
Debt to Assets

67.0%

7.2x

Debt to EBITDA
Free Cash Flow

-$34.382m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases